Add BrightSurf on Google Email

SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages

10.26.17 | Stand Up To Cancer

Stand Up To Cancer (SU2C), the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, have awarded a total of $16.6 million to four teams of top researchers to carry out an attack on cancers of the lung and pancreas using a radical new approach of "interception" of cancers at very early stages when they can be more successfully treated, even catching precancerous cells and blocking them from turning into cancer cells.

###

Keywords

Contact Information

Jane Rubinstein
Stand Up To Cancer
jrubinstein@eifoundation.org

Source

This article is based on a news release from Stand Up To Cancer. BrightSurf curates and republishes science news from research institutions worldwide; the original release is linked below.

How to Cite This Article

APA:
Stand Up To Cancer. (2017, October 26). SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages. Brightsurf News. https://www.brightsurf.com/news/1GN92ERL/su2c-launches-cancer-interception-initiative-to-detect-treat-cancer-at-earliest-stages.html
MLA:
"SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages." Brightsurf News, Oct. 26 2017, https://www.brightsurf.com/news/1GN92ERL/su2c-launches-cancer-interception-initiative-to-detect-treat-cancer-at-earliest-stages.html.